Globe Life Inc.
GL · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.14 | 7.83 | 32.83 | -0.77 |
| FCF Yield | 1.75% | 2.84% | 3.82% | 3.44% |
| EV / EBITDA | 23.43 | 37.13 | 38.64 | 34.29 |
| Quality | ||||
| ROIC | 17.58% | 12.14% | 1.49% | 14.14% |
| Gross Margin | -43.57% | 41.44% | 42.16% | 100.00% |
| Cash Conversion Ratio | – | – | 1.70 | 1.32 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.04% | 5.29% | 5.29% | 3.48% |
| Free Cash Flow Growth | -29.26% | -29.79% | 30.51% | 3.42% |
| Safety | ||||
| Net Debt / EBITDA | 0.18 | 7.33 | 7.32 | 7.40 |
| Interest Coverage | 14.20 | 10.15 | 10.21 | 10.49 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 43.37 | -13.25 | -15.42 | -14.41 |